{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:48:59Z","timestamp":1789368539455,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1124\/dmd.110.033605","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T02:10:43Z","timestamp":1274839843000},"page":"1449-1455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Metabolite Formation Kinetics and Intrinsic Clearance of Phenacetin, Tolbutamide, Alprazolam, and Midazolam in Adenoviral Cytochrome P450-Transfected HepG2 Cells and Comparison with Hepatocytes and In Vivo"],"prefix":"10.1016","volume":"38","author":[{"given":"M. Teresa","family":"Donato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hallifax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brian","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jos\u00e9","family":"Gomez-Lech\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.033605_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.10545","article-title":"High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism","volume":"93","author":"Ansede","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.110.033605_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2133\/dmpk.24.209","article-title":"Simultaneous expression of plural forms of human cytochrome P450 at desired ratios in HepG2 cells: adenovirus-mediated tool for cytochrome P450 reconstitution","volume":"24","author":"Aoyama","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.110.033605_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0049825031000076177","article-title":"Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes","volume":"33","author":"Bachmann","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/B:MCBI.0000038232.61760.9e","article-title":"Adenovirus mediated overexpression of CYP2E1 increases sensitivity of HepG2 cells to acetaminophen induced cytotoxicity","volume":"262","author":"Bai","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/dmd.110.033605_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","article-title":"Use of recombinant adenovirus for metabolic engineering of mammalian cells","volume":"43","author":"Becker","year":"1994","journal-title":"Methods Cell Biol"},{"key":"10.1124\/dmd.110.033605_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0887-2333(99)00069-7","article-title":"High expression of human CYP2C in immortalized human liver epithelial cells","volume":"13","author":"Bort","year":"1999","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.110.033605_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/dmd.106.011569","article-title":"Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance","volume":"35","author":"Brown","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"#cr-split#-10.1124\/dmd.110.033605_bib8.1","unstructured":"Castell JV, G\u00f3mez-Lech\u00f3n MJ, Jover R, Lahoz A (2005), inventors"},{"key":"#cr-split#-10.1124\/dmd.110.033605_bib8.2","unstructured":"Advanced In Vitro Cell Technology, assignees. Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans. World Patent WO2005068611. 2005 July 28."},{"key":"10.1124\/dmd.110.033605_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.gt.3300416","article-title":"Adenovirus-mediated gene transfer into human hepatocytes: analysis of the biochemical functionality of transduced cells","volume":"4","author":"Castell","year":"1997","journal-title":"Gene Ther"},{"key":"10.1124\/dmd.110.033605_bib10","first-page":"180","article-title":"Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research","volume":"26","author":"Crespi","year":"1995","journal-title":"Adv Drug Res"},{"key":"10.1124\/dmd.110.033605_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.110.033605_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0168-8278(99)80049-X","article-title":"Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models","volume":"31","author":"Donato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.110.033605_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abio.1993.1381","article-title":"A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates","volume":"213","author":"Donato","year":"1993","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.110.033605_bib14","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.106.009670","article-title":"Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts","volume":"34","author":"Donato","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jmb.2004.03.036","article-title":"A glucose response element from the S. cerevisiae hexose transporter HXT1 gene is sensitive to glucose in human fibroblasts","volume":"338","author":"Ferrer-Mart\u00ednez","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1124\/dmd.110.033605_bib16","doi-asserted-by":"crossref","first-page":"25129","DOI":"10.1016\/S0021-9258(19)74015-0","article-title":"Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism","volume":"267","author":"G\u00f3mez-Foix","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.033605_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.pa.35.040195.002101","article-title":"Cytochromes P450 expression systems","volume":"35","author":"Gonzalez","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.110.033605_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11095-006-9531-2","article-title":"Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance","volume":"23","author":"Hakooz","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.110.033605_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00498250701834665","article-title":"Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines","volume":"38","author":"Hallifax","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/138920009787846341","article-title":"Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro human experimental systems","volume":"10","author":"Hallifax","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.110.033605_bib21","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1124\/dmd.105.005389","article-title":"Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines","volume":"33","author":"Hallifax","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(24)15358-5","article-title":"In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model","volume":"28","author":"Houston","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11095-004-9015-1","article-title":"Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches","volume":"22","author":"Ito","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.110.033605_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(96)00184-2","article-title":"Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data","volume":"73","author":"Iwatsubo","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.110.033605_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/bbrc.1996.1325","article-title":"Induction of 5-aminolevulinate synthase by drugs is independent of increased apocytochrome P450 synthesis","volume":"226","author":"Jover","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.110.033605_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0026-895X(24)12112-8","article-title":"Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation","volume":"61","author":"Khan","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.110.033605_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4","volume":"36","author":"Kronbach","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.110.033605_bib28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.104.000026","article-title":"Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance","volume":"32","author":"McGinnity","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0042-6822(88)90302-9","article-title":"A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5","volume":"163","author":"McGrory","year":"1988","journal-title":"Virology"},{"key":"10.1124\/dmd.110.033605_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3727\/000000004783983855","article-title":"Functional activity of human hepatoma cells transfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene","volume":"13","author":"Naiki","year":"2004","journal-title":"Cell Transplant"},{"key":"10.1124\/dmd.110.033605_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/dmd.31.5.580","article-title":"Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro","volume":"31","author":"Naritomi","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35332-7","article-title":"Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms","volume":"292","author":"Perloff","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.033605_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00498250310001646353","article-title":"Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors","volume":"34","author":"Proctor","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/00498250500162870","article-title":"Microsomal prediction of in vivo clearance and associated interindividual variability of six benzodiazepines in humans","volume":"35","author":"Rawden","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/00498250802446286","article-title":"Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance","volume":"38","author":"Stringer","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.033605_bib39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/dmd.108.024810","article-title":"Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions","volume":"37","author":"Stringer","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.033605_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3565(25)38136-X","article-title":"Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2","volume":"265","author":"Tassaneeyakul","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.033605_bib41","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/js980255z","article-title":"Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity","volume":"87","author":"Venkatakrishnan","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.110.033605_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tox.2005.08.003","article-title":"An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics","volume":"216","author":"Vignati","year":"2005","journal-title":"Toxicology"},{"key":"10.1124\/dmd.110.033605_bib43","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1124\/mol.107.043976","article-title":"The nuclear factor-\u03baB pathway regulates cytochrome P450 3A4 protein stability","volume":"73","author":"Zangar","year":"2008","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624024553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624024553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.033605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:51:18Z","timestamp":1739897478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624024553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0090955624024553"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.033605","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite Formation Kinetics and Intrinsic Clearance of Phenacetin, Tolbutamide, Alprazolam, and Midazolam in Adenoviral Cytochrome P450-Transfected HepG2 Cells and Comparison with Hepatocytes and In Vivo","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.033605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}